Skip to main content

Variability in Cerebrospinal Fluid MicroRNAs Through Life

Molecular Neurobiology volume 57, pages 4134–4142 (2020)Cite this article

Abstract

The development of the human brain starts in the first weeks of embryo differentiation. However, there are many relevant neurodevelopmental processes that take place after birth and during lifespan. Such a fine and changing scenario requires the coordinated expression of thousands of genes to achieve the proper specialization and inter-connectivity. In this context, microRNAs (miRNAs), which can modulate mRNA stability and translation, are gaining recognition for their involvement in both brain development and neurodevelopmental disorders. Therefore, cerebrospinal fluid (CSF) miRNAs should be perfectly differentiated in relevant age periods. In this study, we aimed to highlight the biological variability of miRNA expression in the CSF throughout life, which is also crucial for biomarker discovery in CNS pathologies, especially in children, where they are desperately needed. We analyzed the CSF microRNAome of 14 healthy children (aged 0–7.4 years) by smallRNA-Seq and compared it with previously published data in adults (N = 7) and elders (N = 11). miR-423-5p and miR-22-3p were overexpressed in the < 1 and > 3 years groups, respectively. Additionally, we detected 18 miRNAs that reached their highest peak of expression at different time-points during the lifespan and sets of miRNAs that were exclusively expressed in a specific age group. On the contrary, miR-191-5p showed stable expression in CSF from the first year of life. Our results remark the complex differential miRNA expression profile that can be observed through life, which underlines the need for including appropriate age-matched controls when the expression of CSF miRNAs is analyzed in different pathological contexts.

Graphical abstract

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

<1:

Less than 1 year group

1-2:

From 1 to 2 years group

>3:

More than 3 years group

ADU:

Adult group

CHI:

Children (individuals from 0 to 7.4 years old)

CSF:

Cerebrospinal fluid

CPDB:

ConsensusPathDB web tool

ELD:

Elderly group

EVs:

Extracellular vesicles

KEGG:

Kyoto Encyclopedia of Genes and Genomes

mRNA:

Messenger RNA

miRNA:

MicroRNA

RT-qPCR:

Quantitative PCR

SmallRNAseq:

Small RNA sequencing

References

  1. Jernigan TL, Stiles J (2017) Construction of the human forebrain. Wiley Interdiscip Rev Cogn Sci, 8

  2. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10:389–402

    Article  CAS  Google Scholar 

  3. Ma Q, Zhang L, Pearce WJ (2019) MicroRNAs in brain development and cerebrovascular pathophysiology. Am J Physiol Cell Physiol, 317: C3–19

  4. Blandford SN, Galloway DA, Moore CS (2018) The roles of extracellular vesicle microRNAs in the central nervous system. Glia. 66:2267–2278

    Article  Google Scholar 

  5. Prieto-Fernández E, Aransay AM, Royo F, González E, Lozano JJ, Santos-Zorrozua B, Macias-Camara N, González M et al (2019) A comprehensive study of vesicular and non-vesicular miRNAs from a volume of cerebrospinal fluid compatible with clinical practice. Theranostics. 9:4567–4579

    Article  Google Scholar 

  6. Godoy PM, Bhakta NR, Barczak AJ, Cakmak H, Fisher S, MacKenzie TC, Patel T, Price RW et al (2018) Large differences in small RNA composition between human biofluids. Cell Rep 25:1346–1358

    Article  CAS  Google Scholar 

  7. Burgos K, Malenica I, Metpally R, Courtright A, Rakela B (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. PLoS One 9:e94839

    Article  Google Scholar 

  8. Murillo OD, Thistlethwaite W, Rozowsky J, Subramanian SL, Lucero R, Shah N, Jackson AR, Srinivasan S et al (2019) exRNA atlas analysis reveals distinct extracellular RNA cargo types and their carriers present across human biofluids. Cell. 177:463–477

    Article  CAS  Google Scholar 

  9. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25

    Article  Google Scholar 

  10. Dweep H, Gretz N (2015) MiRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 12:697

    Article  CAS  Google Scholar 

  11. Kamburov A, Stelzl U, Lehrach H, Herwig R (2013) The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res 41:D793–D800

    Article  CAS  Google Scholar 

  12. Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B et al (2018) The Reactome pathway knowledgebase. Nucleic Acids Res 46:D649–D655

    Article  CAS  Google Scholar 

  13. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353–D361

    Article  CAS  Google Scholar 

  14. Dyck LIV, Morrow EM (2017) Genetic control of postnatal human brain growth. Curr Opin Neurol 30:114–124

    Article  Google Scholar 

  15. Silbereis JC, Pochareddy S, Zhu Y, Li M, Sestan N (2016) The cellular and molecular landscapes of the developing human central nervous system. Neuron. 89:248–268

    Article  CAS  Google Scholar 

  16. Dubois J, Alison M, Counsell SJ, Lucie HP, Hüppi PS, Benders MJNL (2020) MRI of the neonatal brain: a review of methodological challenges and Neuroscientific advances. J Magn Reson Imaging. https://doi.org/10.1002/jmri.27192

  17. Camacho MC, Quiñones-Camacho LE, Perlman SB (2019) Does the child brain rest?: an examination and interpretation of resting cognition in developmental cognitive neuroscience. Neuroimage. 212:116688

    Article  Google Scholar 

  18. Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R et al (2011) MicroRNA-423 promotes cell growth and regulates G 1/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis. 32:1641–1647

    Article  CAS  Google Scholar 

  19. Xu J, He J, Huang H, Peng R, Xi J (2018) MicroRNA-423-3p promotes glioma growth by targeting PANX2. Oncol Lett 16:179–188

    PubMed  PubMed Central  Google Scholar 

  20. dos Santos MCT, Barreto-Sanz MA, Correia BRS et al (2018) miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease. Oncotarget 9:17455–17465

    Article  Google Scholar 

  21. Elsharawy A, Keller A, Flachsbart F et al (2012) Genome-wide miRNA signatures of human longevity. Aging Cell 11:607–616

    Article  CAS  Google Scholar 

  22. Wang X, Shi C, Pan H, Meng XJF (2020) MicroRNA-22 exerts its neuroprotective and angiogenic functions via regulating PI3K/Akt signaling pathway in cerebral ischemia-reperfusion rats. J Neural Transm 127:35–44

    Article  CAS  Google Scholar 

  23. Wang Y, Zhao L, Kan B, Shi H, Han J (2018) miR-22 exerts anti-Alzheimic effects via the regulation of apoptosis of hippocampal neurons. Cell Mol Biol 64:84–89

    Article  Google Scholar 

  24. Ma J, Shui S, Han X, Guo D, Li T, Yan L (2016) microRNA-22 attenuates neuronal cell apoptosis in a cell model of traumatic brain injury. Am J Transl Res 8:1895–1902

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos M d F, Luthi-Carter R (2013) MicroRNA-22 (miR-22) Overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington’s disease-related mechanisms. PLoS One 8:e54222

    Article  CAS  Google Scholar 

  26. Jauhari A, Yadav S (2019) MiR-34 and MiR-200: regulator of cell fate plasticity and neural development. NeuroMolecular Med 21:97–109

    Article  CAS  Google Scholar 

  27. Jauhari A, Singh T, Singh P, Parmar D, Yadav S (2018) Regulation of miR-34 family in neuronal development. Mol Neurobiol 55:936–945

    Article  CAS  Google Scholar 

  28. Kennerdell JR, Liu N, Bonini NM (2018) MiR-34 inhibits polycomb repressive complex 2 to modulate chaperone expression and promote healthy brain aging. Nat Commun 9:4188

    Article  Google Scholar 

  29. Wu YC, Chawla G SN (2020) let-7-Complex MicroRNAs regulate broad-Z3, which together with chinmo maintains adult lineage neurons in an immature state. G3.

  30. Chen J, Ouyang HUI, An X, Liu S (2019) miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53. Oncol Lett 17:87–94

    CAS  PubMed  Google Scholar 

  31. Zhang X, Zhong B, Zhang W, Wu JWY, Circular RNA (2019) CircMTO1 inhibits proliferation of glioblastoma cells via miR-92/WWOX signaling pathway. Med Sci Monit 25:6454–6461

    Article  CAS  Google Scholar 

  32. Peng G, Yuan X, Yuan J, Liu Q, Dai M, Shen C, Ma J, Liao Y et al (2015) miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. Mol Cell Biochem 409:103–111

    Article  CAS  Google Scholar 

  33. Herrera-Espejo S, Santos-Zorrozua B, Álvarez-González P, Lopez-Lopez E, Garcia-Orad Á (2019) A systematic review of MicroRNA expression as biomarker of late-onset Alzheimer’s disease. Mol Neurobiol 56:8376–8391

    Article  CAS  Google Scholar 

  34. Huang Z, Shi J, Gao Y et al (2019) HMDD v3.0: A database for experimentally supported human microRNA-disease associations. Nucleic Acids Res 47:D1013–D1017

    Article  CAS  Google Scholar 

  35. Yang SY, Choi SA, Lee JY, Park AK, Wang KC, Phi JH, Koh EJ, Park WY et al (2015) miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47. Oncotarget. 6:43712–43730

    Article  Google Scholar 

  36. Pierson J, Hostager B, Fan R, Vibhakar R (2008) Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neuro-Oncol 90:1–7

    Article  CAS  Google Scholar 

  37. Dai J, Li Q, Bing Z, Zhang Y, Niu L, Yin H, Yuan G, Pan Y (2017) Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma. Mol Med Rep 15:4109–4115

    Article  CAS  Google Scholar 

  38. Venkataraman S, Alimova I, Fan R, Harris P, Foreman N, Vibhakar R (2010) MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One 5:e10748

    Article  Google Scholar 

  39. Maldonado-Lasuncion I, Atienza M, Sanchez-Espinosa MP, Cantero JL (2019) Aging-related changes in cognition and cortical integrity are associated with serum expression of candidate microRNAs for Alzheimer disease. Cereb Cortex 29:4426–4437

    Article  Google Scholar 

  40. Manzano-Crespo M, Atienza M, Cantero JL (2019) Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1-40 and cerebral vulnerability in normal aging. Transl Neurodegener 8:34

    Article  Google Scholar 

  41. Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J et al (2017) A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 8:68769–68779

    Article  Google Scholar 

  42. Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, Enslin N, Solomons R et al (2019) Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity. Nat Commun 10:3767

    Article  Google Scholar 

  43. Saugstad JA, Lusardi TA, Van Keuren-Jensen KR et al (2017) Analysis of extracellular RNA in cerebrospinal fluid. J Extracell Vesicles 6:1317577

    Article  Google Scholar 

  44. Waller R, Wyles M, Heath PR, Kazoka M, Wollff H, Shaw PJ, Kirby J (2018) Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci 11:731

    Article  Google Scholar 

Download references

Acknowledgments

We extend special thanks to the Department of Pediatric Emergency team at Cruces University Hospital for their collaboration in obtaining clinical samples: Yordana Acedo, Pilar Alonso, Beatriz Azkunaga, Yolanda Ballestero, Elena Daghoum, Ana Fernandez, Iker Gangoiti, Silvia Garcia, Borja Gomez, María Gonzalez, Edurne Lopez, Roser Martinez, Santiago Mintegi, Ohiane Morientes, Mikel Olabarri, Natalia Paniagua, and María Angeles Ruiz.

Funding

This work was supported by the Basque Government (IT989-16), the Spanish Ministry of Economy and Competitiveness MINECO (SAF2015-66312), and the Ramon Areces Foundation (FRA-17-JMF). We thank MINECO for the TenTaCles (Spanish Excellence Network in Exosomes) and the Severo Ochoa Excellence Accreditation (SEV-2016-0644).

Author information

Authors and Affiliations

  1. Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of The Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain

    Endika Prieto-Fernández, Elixabet Lopez-Lopez, Idoia Martin-Guerrero & Africa Garcia-Orad

  2. BioCruces Bizkaia Health Research Institute, 48903, Barakaldo, Bizkaia, Spain

    Elixabet Lopez-Lopez, Idoia Martin-Guerrero & Africa Garcia-Orad

  3. Genome Analysis Platform, CIC bioGUNE, 48160, Derio, Bizkaia, Spain

    Laura Bárcena, Monika Gonzalez-Lopez & Ana María Aransay

  4. Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain

    Ana María Aransay & Juan Manuel Falcón-Pérez

  5. Bioinformatic Platform, Hospital Clinic, CIBERehd, 08036, Barcelona, Spain

    Juan José Lozano

  6. Department of Pediatric Emergency, Cruces University Hospital, 48903, Barakaldo, Bizkaia, Spain

    Javier Benito

  7. Department of Pediatrics, University of The Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain

    Javier Benito

  8. Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain

    Juan Manuel Falcón-Pérez

  9. IKERBASQUE, Basque Foundation for Science, 48015, Bilbao, Bizkaia, Spain

    Juan Manuel Falcón-Pérez

Authors
  1. Endika Prieto-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elixabet Lopez-Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Idoia Martin-Guerrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Bárcena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monika Gonzalez-Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana María Aransay
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Juan José Lozano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Javier Benito
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Juan Manuel Falcón-Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Africa Garcia-Orad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Endika Prieto-Fernández, Elixabet Lopez-Lopez or Idoia Martin-Guerrero.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 294 kb)

ESM 2

(XLSX 78 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Prieto-Fernández, E., Lopez-Lopez, E., Martin-Guerrero, I. et al. Variability in Cerebrospinal Fluid MicroRNAs Through Life. Mol Neurobiol 57, 4134–4142 (2020). https://doi.org/10.1007/s12035-020-02011-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-020-02011-3

Keywords

  • Cerebrospinal fluid
  • MicroRNAs
  • Children
  • Biomarkers
  • Biological variability